143 filings
8-K
RNAC
Cartesian Therapeutics Inc
22 May 24
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis
7:08am
8-K
RNAC
Cartesian Therapeutics Inc
8 May 24
Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
7:03am
8-K
RNAC
Cartesian Therapeutics Inc
22 Apr 24
Other Events
6:25am
8-K
RNAC
Cartesian Therapeutics Inc
9 Apr 24
Regulation FD Disclosure
7:00am
8-K
RNAC
Cartesian Therapeutics Inc
1 Apr 24
Departure of Directors or Certain Officers
4:32pm
8-K
emvlj dfa9k8e46h
28 Mar 24
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split
5:00pm
8-K
bgzm3l
14 Mar 24
Termination of a Material Definitive Agreement
7:55am
8-K
gijgfek
7 Mar 24
Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
7:06am
8-K
z49wyk
5 Mar 24
Entry into a Material Definitive Agreement
7:05am
8-K/A
woosn6a75
23 Jan 24
Independent Auditor’s Report
4:05pm
8-K
1dz82
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:12pm
8-K
njm1gotvy0ro66
8 Jan 24
Regulation FD Disclosure
8:45am
8-K
c2yk9d
27 Nov 23
Departure of Directors or Certain Officers
4:18pm
8-K
thu9 6gj8jy8l
13 Nov 23
Entry into a Material Definitive Agreement
9:02am
8-K
4v0hf0u cd
31 Oct 23
Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
4:06pm
8-K
ftseyojxbvjkr
25 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
8e6ljb0bvg0ix2t0p
13 Sep 23
Other Events
7:33am
8-K
sgendyazbqr 8bly
17 Aug 23
Results of Operations and Financial Condition
7:10am
8-K
hzyycp71 f1xs21
16 Jun 23
Submission of Matters to a Vote of Security Holders
4:20pm
8-K
pj1vr
4 Apr 23
Entry into a Material Definitive Agreement
4:16pm